Neurology Articles

Neurology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ludolph AC et al. – The authors review treatment development in motor neuron disease and discuss the strengths and limitations of past as well as upcoming clinical trials.

Related Articles

Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis
Brain, 11/30/09    Relevance Score: 83%

Vocal Cord Dysfunction in Amyotrophic Lateral Sclerosis: Four Cases and a Review of the Literature
Archives of Neurology, 11/19/09    Relevance Score: 82%

Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: A phase II open label clinical trial
Amyotrophic Lateral Sclerosis, 12/01/09    Relevance Score: 80%

Cervical spondylotic amyotrophy presenting as dropped head syndrome
Clinical Neurology and Neurosurgery, 11/13/09    Relevance Score: 80%

A cluster of amyotrophic lateral sclerosis in New Hampshire: A possible role for toxic cyanobacteria blooms
Amyotrophic Lateral Sclerosis, 11/20/09    Relevance Score: 79%

Today in Demyelinating Disorders...keeping you current

MRI-based functional neuroimaging in ALS: An update
Amyotrophic Lateral Sclerosis, 12/07/09

Cyanobacteria, neurotoxins and water resources: are there implications for human neurodegenerative disease
Amyotrophic Lateral Sclerosis, 12/07/09

Micro-ribonucleic acid profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47
Brain, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address